NDAORALTABLET, EXTENDED RELEASE
Approved
Nov 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Indications (7)
these symptoms due to hay feverother upper respiratory allergies: sneezing itchywatery eyes runny nose itching of the nosethroat temporarily relieves nasal congestion due to the common coldhay feverother upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestionpressure temporarily restores freer breathing through the nose
Clinical Trials (2)
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects
Started Apr 2018
29 enrolled
Clinical Pharmacology
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects
Started Apr 2018
52 enrolled
Clinical Pharmacology